𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combination treatment with extracorporeal photopheresis, interferon alfa and interleukin-2 in a patient with the Sézary syndrome

✍ Scribed by Fritz; Kleinhans; Nestle; Burg; Dummer

Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
221 KB
Volume
140
Category
Article
ISSN
0007-0963

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon alfa-2b in combination with r
Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: Efficacy, safety, and pharmacokinetics
✍ Regino P. González-Peralta; Deirdre A. Kelly; Barbara Haber; Jean Molleston; Kar 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 3 views

Chronic hepatitis C virus (HCV) infection is usually asymptomatic in children, but significant liver disease may occur. We evaluated the efficacy, safety, and pharmacokinetics of interferon alfa-2b and ribavirin in children with chronic HCV. We determined the optimal ribavirin dose in an initial coh

Subcutaneous interleukin-2 and interfero
Subcutaneous interleukin-2 and interferon α in the treatment of patients with metastatic renal cell carcinoma—Less efficacy compared with intravenous interleukin-2 and interferon α : Results of a multicenter Phase II trial from the Groupe Français d'Immunothérapie
✍ Alain Ravaud; Rémy Delva; Fréderic Gomez; Christine Chevreau; Jean-Yves Douillar 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 1 views

## Background: The main objective of this trial was to evaluate the combination of subcutaneous (sc) interleukin-2 (il-2) with interferon alpha-2a (ifn-alpha) in the treatment of patients with metastatic renal cell carcinoma (mrcc) compared with a previous trial that used continuous-infusion il-2 a

Medroxyprogesterone, interferon alfa-2a,
Medroxyprogesterone, interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis : Results of a randomized controlled trial
✍ Sylvie Negrier; David Perol; Alain Ravaud; Christine Chevreau; Jacques-Olivier B 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB

## Abstract ## BACKGROUND. Few randomized trials have compared the survival benefit of interferon‐alfa over controls in metastatic renal cell carcinoma, and none has been performed using interleukin‐2. The Programme Etude Rein Cytokines (PERCY) Quattro trial was designed to evaluate both cytokines

Randomized trial of treatment with cispl
Randomized trial of treatment with cisplatin and interleukin-2 either alone or in combination with interferon-α-2a in patients with metastatic melanoma : A Federation Nationale des Centres de Lutte Contre le Cancer Multicenter, parallel study
✍ Thierry Dorval; Sylvie Négrier; Christine Chevreau; Marie-Françoise Avril; Danie 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

## Background: The objective of the current study was to evaluate the response rate, survival, and toxicity of treatment with cisplatin and high dose intravenous continuous infusion interleukin-2 (il-2) with or without interferon-alpha-2a (ifn) in patients with metastatic melanoma. ## Methods: On

Is an “à la carte” combination interfero
Is an “à la carte” combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C?
✍ Thierry Poynard; John McHutchison; Zachary Goodman; Mei-Hsiu Ling; Janice Albrec 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 1 views

Randomized trials have shown the enhancement of efficacy with interferon alfa-2b and ribavirin (IFN-R) in comparison with interferon monotherapy (IFN) as first line treatment of chronic hepatitis C. Further definition of response based on disease, patient, and treatment characteristics is needed to